Riskpilot← Back to searchSign inGet full accessTreatplan i Sverige AB
ABActiveOrg 5592832587Kistagången 2-4Wholesale of fruit and vegetables · NACE 4631Est. 20200 employees
Revenue 2025
SEK 360K
+53% vs 2024
EBITDA margin
31.9%
+61% vs 2024
Equity ratio
83.5%
Financial strength
Net profit 2025
SEK 91K
+49% vs 2024
| Revenue | SEK 360K | +53% |
| EBITDA | SEK 115K | +61% |
| Net profit | SEK 91K | +49% |
| Total assets | SEK 245K | +26% |
| Equity | SEK 204K | +80% |
| Employees | 0 | — |
Legal name
Treatplan i Sverige AB
Org number
5592832587
Legal form
Aktiebolag
NACE code
4631 · Wholesale of fruit and vegetables
Founded
16 november 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva sjukvårdsrådgivning samt därmed förenlig verksamhet.
Address
Kistagången 2-4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | — | — | 235 | 360 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −10 | −6 | −7 | 71 | 115 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −10 | −6 | −7 | 71 | 115 |
| Net financials | — | — | — | −0 | 0 |
| Profit before tax | −10 | −6 | −7 | 71 | 115 |
| Tax | −0 | — | — | −10 | −24 |
| Net profit | −10 | −6 | −7 | 61 | 91 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 15 | 59 | 52 | 194 | 245 |
| Equity | 15 | 59 | 52 | 113 | 204 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 0 | — | — | 81 | 40 |
| Total debt | — | — | — | 81 | 40 |
EBITDA margin
31.9%
This company
15.8%
Market median
+102% vs market
20212025
Equity ratio
83.5%
This company
38.2%
Market median
+119% vs market
20212025
Return on equity
44.6%
This company
18.4%
Market median
+142% vs market
20212025
Net profit margin
25.3%
This company
8.1%
Market median
+212% vs market
20212025
Asset turnover
1.47×
This company
1.12×
Market median
+31% vs market
20212025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2023 | |
| Board of Directors | 2022 | |
| Former (6) | ||
| Chairman | 2021 – 2022 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2022 – 2023 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Treatplan i Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| M H Charlotte Wiberg Larsson | Chairman | 0 companies |
| Per Rudolf Hulin | Board of Directors | 0 companies |
| Bo Torsten Nilsson | Board of Directors | 0 companies |
| Ramona Moussally | Deputy Board Member | 0 companies |
| Josef Zaito | Board of Directors | 0 companies |
| Peter Jonas Michael Carlborg | Deputy Board Member | 0 companies |
| Carl Johan Alexander Elsner | Board of Directors | 0 companies |
| Bo Torsten Patrik Nilsson | Deputy Board Member | 0 companies |